What Is Semaglutide?

Semaglutide is one of the most widely discussed medications of the past decade — and for good reason. Originally developed to treat type 2 diabetes, it has since become a cornerstone of modern weight management. But despite its popularity, many patients starting semaglutide have surprisingly limited information about what it actually does in the body, how to use it safely, and what to realistically expect.

This guide covers everything you need to know — in plain language, without oversimplifying the science.

How Does Semaglutide Work?

Semaglutide is a GLP-1 receptor agonist. GLP-1 stands for glucagon-like peptide-1 — a hormone your body naturally produces in the gut after eating. Semaglutide mimics this hormone, binding to GLP-1 receptors throughout the body.

This triggers several important effects:

• Slows gastric emptying — food moves through your stomach more slowly, keeping you feeling full longer
• Reduces appetite — acts on appetite centers in the brain to reduce hunger signals
• Stimulates insulin release — increases insulin production in response to meals, lowering blood sugar
• Reduces glucagon — suppresses the hormone that raises blood sugar between meals

What Is Semaglutide Used For?

1. Type 2 Diabetes (Ozempic®)

Ozempic was FDA-approved in 2017 for adults with type 2 diabetes to improve blood sugar control. It's used alongside diet and exercise and is available in doses up to 2.0 mg weekly. It also has a proven cardiovascular benefit — the SUSTAIN-6 trial showed a significant reduction in major cardiovascular events.

2. Chronic Weight Management (Wegovy®)

Wegovy was FDA-approved in 2021 specifically for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related condition. It uses a higher maximum dose of 2.4 mg weekly. The SELECT trial published in 2023 also demonstrated significant cardiovascular risk reduction in people with obesity and established heart disease.

3. Compounded Semaglutide

Due to ongoing shortages of brand-name Wegovy and Ozempic, compounded semaglutide has become widely available through telehealth platforms and compounding pharmacies. Compounded versions are not FDA-approved as finished products but are legal to produce under certain conditions. They require a prescription and careful attention to concentration and dosing.

How Is Semaglutide Taken?

Injectable (Most Common)

The injectable form is administered once weekly via subcutaneous injection — meaning just under the skin, not into a muscle. Common injection sites include the abdomen, upper thigh, or upper arm. Brand-name versions come as pre-filled auto-injector pens. Compounded versions typically come as vials requiring a syringe.

Oral (Rybelsus®)

An oral tablet form (Rybelsus) is available for type 2 diabetes, taken once daily. It requires specific administration instructions — taken on an empty stomach with no more than 4 oz of water, waiting 30 minutes before eating.

Dosing and Titration

Semaglutide is always started at a low dose and gradually increased over several months. This titration process exists to minimize side effects — particularly nausea — while your body adapts to the medication.

A typical Wegovy titration schedule:

• Weeks 1–4: 0.25 mg weekly
• Weeks 5–8: 0.5 mg weekly
• Weeks 9–12: 1.0 mg weekly
• Weeks 13–16: 1.7 mg weekly
• Week 17+: 2.4 mg weekly (maintenance)

Compounded semaglutide is typically measured in mg/mL concentration and requires a syringe to draw the correct volume. Use our free dose calculator to convert your prescribed dose to syringe units.

What Results Can You Expect?

Clinical trial data from the STEP program showed an average weight loss of approximately 15% of body weight over 68 weeks at the 2.4 mg dose. Individual results vary significantly based on adherence, diet, exercise, and metabolic factors.

• Weeks 1–4: Appetite reduction begins, some nausea common, minimal weight change
• Month 2–3: Weight loss becomes noticeable, side effects typically improve
• Month 4–6: Significant weight loss for most patients reaching therapeutic dose
• Month 6–12: Continued weight loss, plateau common as body adapts
• 12+ months: Maintenance phase — most patients require continued use to maintain results

Common Side Effects

• Nausea — most common, particularly in the first weeks after dose increases
• Vomiting — less common, usually manageable
• Diarrhea or constipation — affects some patients
• Fatigue — reported by some patients, particularly early in treatment
• Injection site reactions — redness, bruising, or mild irritation

Frequently Asked Questions

How long does semaglutide stay in your system?

Semaglutide has a half-life of approximately 7 days. Use our half-life calculator to see how long it stays active based on your dose.

What happens if you miss a dose?

Take it as soon as possible — as long as your next scheduled dose is more than 2 days away. Use our missed dose tool for a personalized recommendation.